What makes Exponent (EXPO) an attractive investment opportunity?
investment opportunity Conestoga Capital Advisors, an asset management company, released its “Mid Cap Strategy” first-quarter 2023 investor letter. A copy of the same can be downloaded here. The Mid Cap Composite rose 10.23% net of fees in the first quarter, compared to the Russell Midcap Growth Index’s 9.14% return.
The strategy primarily benefited from the stock selection while the sector allocation also contributed to the relative performance. In addition, please check the fund’s top five holdings to know its best picks in 2023
Conestoga Mid Cap Strategy In its 2023 First Quarter Investor Letter, Exponent, Inc. (NASDAQ:EXPO) . Menlo Park, Calif., Exponent, Inc. (NASDAQ: EXPO) is a science and engineering consulting company headquartered in. On May 26, 2023, Exponent, Inc. (NASDAQ:EXPO) stock closed at $91.98 per share.
Exponent, Inc. (NASDAQ:EXPO) had a one-month return of -0.08%, and its shares gained 1.21% of their value over the past 52 weeks. Exponent, Inc. (NASDAQ: EXPO) has a market capitalization of $4.676 billion.
Conestoga Mid Cap Strategy In its Q1 2023 Investor Letter, Exponent, Inc. (NASDAQ: EXPO) made the following comments regarding:
Exponent, Inc. (NASDAQ: EXPO): Founded in 1967 and headquartered in Menlo Park, CA, EXPO is a global engineering and consulting company that specializes in the analysis of products, people, assets, processes and finances related to litigation, product recalls. , regulatory compliance and development and design. EXPO has more than 750 employees, of whom more than 450 have PhDs in their field of expertise.
EXPO benefits from the breadth of its services, offering more than 90 topics compared to the typical competitor’s five or fewer. EXPO has been a steady producer that generates a significant amount of cash flow, which has historically been used to benefit shareholders.
With litigation and high profile accidents (BP Oil Spill, DeflateGate, Toyota Unexpected Acceleration Recall, etc.) as sources of their demand, the company operates a business model that is less sensitive to the macro economy. The expo also aligns with our small cap and mid cap growth strategy.
Exponent, Inc. (NASDAQ: EXPO) isn’t on our list of the 30 most popular stocks among hedge funds. As per our database, at the end of Q1 2023 Exponent, Inc. had 23 hedge fund portfolios.
In another article we discussed Exponent, Inc. (NASDAQ: EXPO) and shared a list of the best Consulting stocks to buy. Also, please visit our Hedge Fund Investor Letters Q1 2023 page for more investor letters from hedge funds and other prominent investors.